Recombinant human interleukin-12: Suspended a Phase II trial in patients with advanced kidney cancer following adverse events that led to the hospitalization of

Genetics Institute Inc. (GENIZ) Product: Recombinant human interleukin-12 Indication: Advanced kidney cancer Status: Suspended a Phase II trial in patients with advanced kidney cancer following advers...